{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:57:46Z","timestamp":1795035466782,"version":"4.10.2"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1A6A1A03033084"],"award-info":[{"award-number":["2019R1A6A1A03033084"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022R1A6A3A01086797"],"award-info":[{"award-number":["2022R1A6A3A01086797"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017287","name":"Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126524","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:36:01Z","timestamp":1731573361000},"page":"126524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn\/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice"],"prefix":"10.1016","volume":"43","author":[{"given":"Ji-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Senevirathne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126524_bb0005","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3201\/eid2505.181463","article-title":"Endemic severe fever with thrombocytopenia syndrome","volume":"25","author":"Tran","year":"2019","journal-title":"Vietnam Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126524_bb0010","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3201\/eid2812.221183","article-title":"Severe fever with thrombocytopenia syndrome virus infection, Thailand, 2019-2020","volume":"28","author":"Rattanakomol","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126524_bb0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3201\/eid2405.151435","article-title":"Transmission of severe fever with thrombocytopenia syndrome virus by Haemaphysalis longicornis ticks, China","volume":"24","author":"Zhuang","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126524_bb0020","article-title":"Current Progress of severe fever with thrombocytopenia syndrome virus (SFTSV)","volume":"16","author":"Kim","year":"2024","journal-title":"Vaccine Develop Viruses"},{"key":"10.1016\/j.vaccine.2024.126524_bb0025","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126524_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41541-020-00257-5","article-title":"Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development","volume":"5","author":"Bopp","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126524_bb0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3201\/eid1905.120245","article-title":"Severe fever with thrombocytopenia syndrome virus among domesticated animals","volume":"19","author":"Niu","year":"2013","journal-title":"China Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126524_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2014.01.011","article-title":"Emerging phleboviruses","volume":"5","author":"Elliott","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","article-title":"Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy","volume":"53","author":"Casel","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.vaccine.2024.126524_bb0050","first-page":"5","article-title":"Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea","author":"Yun","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2024.126524_bb0055","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s40121-022-00693-x","article-title":"Antiviral treatment options for severe fever with thrombocytopenia syndrome infections","volume":"11","author":"Zhang","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.126524_bb0060","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126524_bb0065","first-page":"15","article-title":"An mRNA-based multiple antigenic gene expression system delivered by engineered Salmonella for severe fever with thrombocytopenia syndrome and assessment of its immunogenicity and protection using a human DC-SIGN-transduced mouse model","author":"Park","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.126524_bb0070","first-page":"9","article-title":"Highlights of immunomodulation in Salmonella-based cancer therapy","author":"Pangilinan","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.vaccine.2024.126524_bb0075","doi-asserted-by":"crossref","first-page":"25441","DOI":"10.18632\/oncotarget.25192","article-title":"Engineering of a rough auxotrophic mutant Salmonella typhimurium for effective delivery","volume":"9","author":"Lalsiamthara","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2024.126524_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121226","article-title":"Eukaryotic expression system complemented with expressivity of Semliki Forest Virus\u2019s RdRp and invasiveness of engineered Salmonella demonstrate promising potential for bacteria mediated gene therapy","volume":"279","author":"Senevirathne","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.126524_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005893","article-title":"Molecular genomic characterization of tick- and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea","volume":"11","author":"Yun","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.126524_bb0090","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126524_bb0095","doi-asserted-by":"crossref","first-page":"D67","DOI":"10.1093\/nar\/gkv1276","article-title":"GenBank","volume":"44","author":"Clark","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.126524_bb0100","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: immune epitope database-analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.126524_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0301s39","article-title":"Isolation of mouse mononuclear cells","volume":"39","author":"Kruisbeek","year":"2000","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106079","article-title":"Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression","author":"Park","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2024.126524_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2024.126524_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcv.2011.09.031","article-title":"Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay","volume":"53","author":"Sun","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2022.114540","article-title":"Comparison of plaque reduction and focus reduction neutralization tests for the measurement of neutralizing antibody titers against japanese encephalitis virus","volume":"306","author":"Park","year":"2022","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2024.126524_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1066896913517939","article-title":"The wonderful colors of the hematoxylin-eosin stain in diagnostic surgical pathology","volume":"22","author":"Chan","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0140","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.126524_bb0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00018-002-8437-3","article-title":"The role of glycosylation in protein antigenic properties","volume":"59","author":"Lisowska","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2024.126524_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2024.126524_bb0155","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/s41467-021-26367-9","article-title":"Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases","volume":"12","author":"Raman","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126524_bb0160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126524_bb0165","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.vaccine.2024.126524_bb0170","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JVI.02628-12","article-title":"Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines","volume":"87","author":"Hofmann","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106079","article-title":"Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression","volume":"178","author":"Park","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2024.126524_bb0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fcimb.2018.00394","article-title":"Histological disorganization of spleen compartments and severe visceral Leishmaniasis","volume":"8","author":"Hermida","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0185","first-page":"1","article-title":"Research Progress of fever with thrombocytopenia syndrome","author":"Luo","year":"2023","journal-title":"Intensive Care Res"},{"key":"10.1016\/j.vaccine.2024.126524_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106799","article-title":"SFTSV infection is associated with transient overproliferation of monoclonal lambda-type plasma cells","volume":"26","author":"Quan","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2024.126524_bb0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13337-021-00656-9","article-title":"A new emerging pandemic of severe fever with thrombocytopenia syndrome (SFTS)","volume":"32","author":"Sharma","year":"2021","journal-title":"Virusdisease"},{"key":"10.1016\/j.vaccine.2024.126524_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01815-23","article-title":"Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-kappaB signaling pathway","volume":"98","author":"Jia","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0205","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1073\/pnas.1603827113","article-title":"Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion","volume":"113","author":"Halldorsson","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126524_bb0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/AAC.00642-08","article-title":"Sec- and tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane","volume":"53","author":"Pradel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2024.126524_bb0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.vaccine.2021.12.024","article-title":"Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein","volume":"40","author":"Chung","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126524_bb0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0952-7915(98)80123-4","article-title":"Cytotoxic T cell responses to intracellular pathogens","volume":"10","author":"Stenger","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0225","first-page":"21","article-title":"T cell immunity to bacterial pathogens: mechanisms of immune control and bacterial evasion","author":"Shepherd","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.126524_bb0230","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/356796a0","article-title":"MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8","volume":"356","author":"K\u00f6nig","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126524_bb0235","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/s41467-018-05746-9","article-title":"Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection","volume":"9","author":"Song","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126524_bb0240","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","article-title":"Heterologous prime\u2013boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus","volume":"36","author":"Jung","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126524_bb0245","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fmicb.2020.01473","article-title":"Recombinant human adenovirus type 5 co-expressing RABV G and SFTSV Gn induces protective immunity against rabies virus and severe fever with thrombocytopenia syndrome virus in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126524_bb0250","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1038\/s41598-023-35328-9","article-title":"Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126524_bb0255","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"Jin","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126524_bb0260","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2023.04.015","article-title":"Novel pro-and eukaryotic expression plasmid expressing omicron antigens delivered via Salmonella elicited MHC class I and II based protective immunity","volume":"357","author":"Sivasankar","year":"2023","journal-title":"J Control Release"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:43:32Z","timestamp":1734018212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"alternative-id":["S0264410X24012064"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126524","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn\/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126524"}}